CN1875949A - Soft gastrodine capsule and preparation method thereof - Google Patents

Soft gastrodine capsule and preparation method thereof Download PDF

Info

Publication number
CN1875949A
CN1875949A CNA2006100452771A CN200610045277A CN1875949A CN 1875949 A CN1875949 A CN 1875949A CN A2006100452771 A CNA2006100452771 A CN A2006100452771A CN 200610045277 A CN200610045277 A CN 200610045277A CN 1875949 A CN1875949 A CN 1875949A
Authority
CN
China
Prior art keywords
gastrodine
capsule
soft
cosolvent
diluent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2006100452771A
Other languages
Chinese (zh)
Inventor
邵爱霞
崔秋菊
付会
蔡杏娟
李志亮
李金才
Original Assignee
邵爱霞
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 邵爱霞 filed Critical 邵爱霞
Priority to CNA2006100452771A priority Critical patent/CN1875949A/en
Publication of CN1875949A publication Critical patent/CN1875949A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)

Abstract

The invention relates to soft capsules containing active ingredient of gastrodine and process for preparation, wherein the capsules are prepared from gastrodine as the main ingredient, the soft capsules have the advantages of high dissolving speed, quick effect, high biological availability, convenience in administration and carrying.

Description

Soft gastrodine capsule and preparation method thereof
One, technical field
The present invention relates to a kind of soft capsule that contains the gastrodine effective ingredient and preparation method thereof, belong to oral solid formulation class medicine, medical technical field.
Two, background technology:
The chemical name of gastrodine is 4-methylol benzene-β-D-pyranglucoside semihydrate; it is the effective ingredient of Chinese medicine Rhizoma Gastrodiae; have calmness, convulsion, epilepsy, analgesia, cerebral blood flow increasing amount, effects such as neuroprotective cell, promotion myocardial cell energy metabolism.Clinically, gastrodine has been widely used in treatment neurasthenia and combined external head injuries, vertigo, neuralgia, headache etc., determined curative effect, safe and reliable.
Dosage forms such as tablet, hard capsule and small-volume injection are arranged in clinical practice, and as the tablet of peroral dosage form, its molten diffusing speed is lower, onset is slow, bioavailability is low, and hard capsule is taken very inconvenient for the patient of old people, bed patient and dysphagia.Though the molten diffusing speed of injection is fast, the bioavailability height, it uses and carries inconvenience, is not suitable for the employee on business trip, takes personnel for a long time.
Three, summary of the invention
The present invention provides a kind of soft gastrodine capsule in order to overcome the deficiency of above technology, has the dissolution height, good looking appearance, advantage easy to carry.
Another object of the present invention is to provide the preparation method of above-mentioned soft gastrodine capsule, it is simple that this preparation method has technology, is suitable for suitability for industrialized production.
Technical scheme of the present invention is as follows:
Soft gastrodine capsule of the present invention is to be the soft capsule that principal agent is made by gastrodine.
Soft gastrodine capsule of the present invention, its pharmaceutic adjuvant are diluent, cosolvent, suspending agent, and the percentage by weight of principal agent and pharmaceutic adjuvant is respectively:
Gastrodine: 10-30%
Diluent: 65-85%
Cosolvent: 0-5.7%
Suspending agent: 0-4%.
Preferably, described diluent is one or more of ethanol, propylene glycol, glycerol, PEG400, soybean oil, Semen Maydis oil, Oleum Gossypii semen and olive oil; Described cosolvent is one or more in beta-schardinger dextrin-, polyoxyethylene sorbitan monoleate, sodium lauryl sulphate, alginic acid, polyvinylpolypyrrolidone and the general methylamine; Described suspending agent is one or more in Cera Flava, glyceryl monostearate, calcium stearate, carmethose, dextrin and the oleic acid.
Preferably, every soft capsule contains gastrodine 5~300mg.
Preferably, its softgel shell is made by glycerol, gelatin, opacifier, antiseptic.
The preparation method of the described soft gastrodine capsule of the invention described above may further comprise the steps:
(1) gets diluent and add the suspending agent heating for dissolving, naturally cool to room temperature under the stirring;
(2) gastrodine is joined in (1), fully stir and make dissolving;
(3) cosolvent is joined in (2), stir and promptly get the content medicinal liquid;
(4) content medicinal liquid and softgel shell glue are inserted in the pellet processing machine simultaneously, be pressed into ball, typing is put the hothouse drying, promptly.
Soft gastrodine capsule of the present invention, promptly increased the peroral dosage form of gastrodine, realized that again gastrodine directly enters in the body molten diffusing speed height with the form of liquid state, the purpose that onset is rapid, bioavailability is high is compared with injection and have been overcome the shortcoming that injection used and carried inconvenience.Soft capsule good looking appearance in addition, patient's compliance is good, and the patient who is particularly suitable for old people, bed patient and dysphagia takes, and this is that other peroral dosage forms can't be than U.S..
Preparation method of the present invention, it is simple to have technology, is suitable for suitability for industrialized production.
Four, the specific embodiment
Below in conjunction with embodiment the present invention is described further, but protection scope of the present invention is not limited to this.Below component content among each embodiment be example all to process 1000.
Embodiment 1:
Soft gastrodine capsule, the content medicinal liquid comprises principal agent and pharmaceutic adjuvant, and principal agent is a gastrodine, and diluent is a soybean oil in the pharmaceutic adjuvant, and suspending agent is a dextrin, and cosolvent is a polyoxyethylene sorbitan monoleate, and the components by weight of its herb liquid is as follows:
Gastrodine 5.0g (10.0%)
Soybean oil 42.0g (84.0%)
Dextrin 1.0g (2%)
Polyoxyethylene sorbitan monoleate 2.0g (4%)
The heavy 50mg of every ball content contains gastrodine 5mg.
Preparation method:
(1) gets soybean oil, add the dextrin heating in water bath and make dissolving, stir, naturally cool to room temperature;
(2) adding gastrodine stirs;
(3) polyoxyethylene sorbitan monoleate is joined in (2), stir, promptly get the content medicinal liquid.
Content medicinal liquid and softgel shell glue are inserted in the pellet processing machine simultaneously, be pressed into ball, typing is put the hothouse drying, promptly.
Embodiment 2:
As described in embodiment 1, the components by weight of different is content medicinal liquid in the soft gastrodine capsule is as follows:
Gastrodine 10.0g (14.0%)
Semen Maydis oil 54.0g (77.0%)
Glyceryl monostearate 4.0g (5.7%)
Beta-schardinger dextrin-2.0g (2.8%)
The heavy 70mg of every ball content contains gastrodine 10mg
Preparation method:
(1) gets Semen Maydis oil, add the glyceryl monostearate heating in water bath and make dissolving, stir, naturally cool to room temperature;
(2) adding gastrodine stirs;
(3) beta-schardinger dextrin-is joined in (2), stir, promptly get the content medicinal liquid.
Content medicinal liquid and softgel shell glue are inserted in the pellet processing machine simultaneously, be pressed into ball, typing is put the hothouse drying, promptly.
Embodiment 3:
As described in embodiment 1, the components by weight of different is content medicinal liquid in the soft gastrodine capsule is as follows:
Gastrodine 20.0g (20%)
PEG400 60.0g (60%)
Glycerol 17.0g (16%)
Alginic acid 3.0g (4%)
The heavy 100mg of every ball content contains gastrodine 20mg.
Preparation method:
(1) taking polyethylene glycol 400, add glycerol and stir;
(2) add gastrodine and stir, heating in water bath makes dissolving, naturally cools to room temperature;
(3) alginic acid joins in (2), stirs, and promptly gets the content medicinal liquid.
Content medicinal liquid and softgel shell glue are inserted in the pellet processing machine simultaneously, be pressed into ball, typing is put the hothouse drying, promptly.
Embodiment 4:
As described in embodiment 1, the components by weight of different is content medicinal liquid in the soft gastrodine capsule is as follows:
Gastrodine 25.0g (20%)
PEG400 75.0g (60%)
Propylene glycol 25.0g (20%)
The heavy 125mg of every ball content contains gastrodine 25mg.
Preparation method:
(1) taking polyethylene glycol 400, add propylene glycol and stir;
(2) add gastrodine and stir, heating in water bath makes dissolving, naturally cools to room temperature;
Content medicinal liquid and softgel shell glue are inserted in the pellet processing machine simultaneously, be pressed into ball, typing is put the hothouse drying, promptly.
Embodiment 5:
As described in embodiment 1, the components by weight of different is content medicinal liquid in the soft gastrodine capsule is as follows:
Gastrodine 50.0g (20%)
PEG400 150.0g (60%)
Ethanol 40.0g (16%)
Polyvinylpolypyrrolidone 10.0g (4%)
The heavy 250mg of every ball content contains gastrodine 50mg.
Preparation method:
(1) taking polyethylene glycol 400, add ethanol and stir;
(2) add gastrodine and stir, heating in water bath makes dissolving, naturally cools to room temperature;
(3) polyvinylpolypyrrolidone joins in (2), stirs, and promptly gets the content medicinal liquid.
Content medicinal liquid and softgel shell glue are inserted in the pellet processing machine simultaneously, be pressed into ball, typing is put the hothouse drying, promptly.
Embodiment 6:
As described in embodiment 1, the components by weight of different is soft gastrodine capsule herb liquid is as follows:
Gastrodine 100.0g (20%)
Oleum Gossypii semen 275.0g (75%)
Cera Flava 10.0g (2%)
Calcium stearate 5.0g (1%)
Sodium lauryl sulphate 10.0g (2%)
The heavy 400mg of every ball content contains gastrodine 100mg.
Preparation method:
(1) get Oleum Gossypii semen, adding Cera Flava, calcium stearate heating in water bath make dissolving, stir, and naturally cool to room temperature;
(2) adding gastrodine stirs;
(3) sodium lauryl sulphate is joined in (2), stir, promptly get the content medicinal liquid.
Content medicinal liquid and softgel shell glue are inserted in the pellet processing machine simultaneously, be pressed into ball, typing is put the hothouse drying, promptly.
Embodiment 7:
As described in embodiment 1, the components by weight of different is soft gastrodine capsule herb liquid is as follows:
Gastrodine 200.0g (28.57%)
Olive oil 470.0g (67.14%)
General methylamine 20.0g (2.56%)
Polyoxyethylene sorbitan monoleate 10.0g (1.43%)
The heavy 700mg of every ball content contains gastrodine 200mg.
Preparation method:
(1) gets olive oil, add general methylamine heating in water bath and make dissolving, stir, naturally cool to room temperature;
(2) adding gastrodine stirs;
(3) polyoxyethylene sorbitan monoleate is joined in (2), stir, promptly get the content medicinal liquid.
Content medicinal liquid and softgel shell glue are inserted in the pellet processing machine simultaneously, be pressed into ball, typing is put the hothouse drying, promptly.
Embodiment 8:
As described in embodiment 1, the components by weight of different is soft gastrodine capsule herb liquid is as follows:
Gastrodine 300.0g (30%)
Soybean oil 650.0g (65%)
Carmethose 30.0g (3%)
General methylamine 10.0g (1%)
Polyoxyethylene sorbitan monoleate 10.0 (1%)
The heavy 1g of every ball content contains gastrodine 300mg.
Preparation method:
(1) get soybean oil, adding carmethose, glyceryl monostearate heating in water bath make dissolving, stir, and naturally cool to room temperature;
(2) adding gastrodine stirs;
(3) polyoxyethylene sorbitan monoleate is joined in (2), stir, promptly get the content medicinal liquid.
Content medicinal liquid and softgel shell glue are inserted in the pellet processing machine simultaneously, be pressed into ball, typing is put the hothouse drying, promptly.
Test case:
Commercially available gastrodine tablet and embodiment of the invention dissolution rate comparative test result
Test method: sample thief, according to dissolution method (two appendix XC of Chinese Pharmacopoeia version in 2005), be solvent with 900ml water, rotating speed is that per minute 75 changes, operation in accordance with the law, respectively at 5 ', 15 ', 25 ', 35 ', 45 ' sampling, filter, get subsequent filtrate, according to high performance liquid chromatography (two appendix VD of Chinese Pharmacopoeia version in 2005), the detection wavelength is 220nm, with calculated by peak area, the results are shown in following table by external standard method:
Sample source Sample time (minute)
5′ 15′ 25′ 35′ 45′
Dissolution (%) Marketed tablet 5.12 28.23 45.44 63.21 78.88
Embodiment 1 6.04 27.44 55.36 92.02 101.33
Embodiment 2 5.44 26.33 58.42 88.63 100.66
Embodiment 3 5.36 25.63 54.23 86.47 101.21
Embodiment 4 5.25 25.36 57.42 90.25 100.37
Embodiment 5 5.64 26.12 60.05 92.44 101.12
Embodiment 6 4.66 24.33 51.14 82.46 97.45
Embodiment 7 4.87 25.12 53.28 86.45 96.68
Embodiment 8 4.69 25.47 55.44 85.88 95.46

Claims (6)

1, a kind of soft gastrodine capsule is characterized in that: be to be the soft capsule that principal agent is made by gastrodine.
2, soft gastrodine capsule as claimed in claim 1 is characterized in that: its pharmaceutic adjuvant is diluent, cosolvent, suspending agent, and the percentage by weight of principal agent and pharmaceutic adjuvant is respectively:
Gastrodine: 10-30%
Diluent: 65-85%
Cosolvent: 0-5.7%
Suspending agent: 0-4%.
3, soft gastrodine capsule as claimed in claim 1 or 2 is characterized in that: described diluent is one or more of ethanol, propylene glycol, glycerol, PEG400, soybean oil, Semen Maydis oil, Oleum Gossypii semen and olive oil; Described cosolvent is one or more in beta-schardinger dextrin-, polyoxyethylene sorbitan monoleate, sodium lauryl sulphate, alginic acid, polyvinylpolypyrrolidone and the general methylamine; Described suspending agent is one or more in Cera Flava, glyceryl monostearate, calcium stearate, carmethose, dextrin and the oleic acid.
4. soft gastrodine capsule as claimed in claim 1 or 2 is characterized in that: every soft capsule contains gastrodine 5~300mg.
5, soft gastrodine capsule as claimed in claim 1 or 2 is characterized in that: its softgel shell is made by glycerol, gelatin, opacifier, antiseptic.
6, the preparation method of the described soft gastrodine capsule of a kind of claim 2 is characterized in that: may further comprise the steps:
(1) gets diluent and add the suspending agent heating for dissolving, naturally cool to room temperature under the stirring;
(2) gastrodine is joined in (1), fully stir and make dissolving;
(3) cosolvent is joined in (2), stir and promptly get the content medicinal liquid;
(4) content medicinal liquid and softgel shell glue are inserted in the pellet processing machine simultaneously, be pressed into ball, typing is put the hothouse drying, promptly.
CNA2006100452771A 2006-07-04 2006-07-04 Soft gastrodine capsule and preparation method thereof Pending CN1875949A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNA2006100452771A CN1875949A (en) 2006-07-04 2006-07-04 Soft gastrodine capsule and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNA2006100452771A CN1875949A (en) 2006-07-04 2006-07-04 Soft gastrodine capsule and preparation method thereof

Publications (1)

Publication Number Publication Date
CN1875949A true CN1875949A (en) 2006-12-13

Family

ID=37508623

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2006100452771A Pending CN1875949A (en) 2006-07-04 2006-07-04 Soft gastrodine capsule and preparation method thereof

Country Status (1)

Country Link
CN (1) CN1875949A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101317971B (en) * 2008-07-02 2011-07-20 贵州益康制药有限公司 Complete-gastrodia tuber soft capsule and preparation method thereof
CN107349186A (en) * 2017-06-28 2017-11-17 新疆金骏阳光生物科技有限公司 Dogbane flower leaf volatile oil soft capsule and preparation method thereof
CN108703955A (en) * 2018-07-31 2018-10-26 荆楚理工学院 A kind of minerals soft capsule and preparation method thereof

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101317971B (en) * 2008-07-02 2011-07-20 贵州益康制药有限公司 Complete-gastrodia tuber soft capsule and preparation method thereof
CN107349186A (en) * 2017-06-28 2017-11-17 新疆金骏阳光生物科技有限公司 Dogbane flower leaf volatile oil soft capsule and preparation method thereof
CN108703955A (en) * 2018-07-31 2018-10-26 荆楚理工学院 A kind of minerals soft capsule and preparation method thereof
CN108703955B (en) * 2018-07-31 2020-02-21 荆楚理工学院 Mineral soft capsule and preparation method thereof

Similar Documents

Publication Publication Date Title
CN101073563A (en) Chiral composition containing dextrothyroxine buprofenli and levomethadyl cysteliqin and its double slow-releasing tablet
CN1709460A (en) Dropping pill of folium ilicis hainanensis and its preparing method
CN1875949A (en) Soft gastrodine capsule and preparation method thereof
CN1883480A (en) A pharmaceutical composition containing rupatatine
CN1709435A (en) Gel formulation for treatig traumatic injury and its preparing method
CN1709236A (en) Fat emulsion containing docetaxel and its preparing method
CN1748758A (en) Dragon's blood gel preparation and its preparing method
CN1720948A (en) Dripping pills of lllicium henryi dripping pills and method for preparing the same
CN1133709A (en) Process for preparing controlled-release tablet of diltiazem hydrochloride
CN1875950A (en) Compound capsule of glycyrrhzin and preparation method thereof
CN1493296A (en) Hemsleya amabilis drip pill and its preparation method
CN1771955A (en) Soft capsule composition of compound cough-relieving and phlegm-eliminating medicine
CN1823752A (en) Soft capsule composition containing acetaminophen
CN1875951A (en) Soft capsule of sodium houttuyfonate and preparation method thereof
CN1686120A (en) Hydrobromic acid high tortoiseshell component drip pill and its preparation method
CN1449750A (en) Gabapentin slow -released composition
CN1634014A (en) Sodium ferulate oral disintegrating tablet and its preparation process
CN100341511C (en) Itraconazole dripping pill and its prepn
CN1686129A (en) Cepharanthine drip pill and its preparation method
CN1891265A (en) Ginseng-aconite orally disintegrating tablet and its preparing method
CN1404832A (en) Gliclazide oral tablet capable of quickly disintegrating and dissolving out and its preparation technology
CN1634004A (en) Ambroxol hydrochloride drop pills and its preparation method
CN1682730A (en) Cepharanthine slow releasing preparation
CN1720946A (en) Bone strengthening dripping pills with Premena fulva craib as raw material and method for preparing the same
CN1872071A (en) Medication for enhancing body immunity, and fighting against senium, and preparation method

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication